| 000 | 01888 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250513031146.0 | ||
| 264 | 0 | _c19941117 | |
| 008 | 199411s 0 0 eng d | ||
| 022 | _a0021-9258 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJonckheere, H | |
| 245 | 0 | 0 |
_aResistance of HIV-1 reverse transcriptase against [2',5'-bis-O-(tert-butyldimethylsilyl)-3'-spiro-5''-(4''-amino-1'',2''- oxathiole-2'',2''-dioxide)] (TSAO) derivatives is determined by the mutation Glu138-->Lys on the p51 subunit. _h[electronic resource] |
| 260 |
_bThe Journal of biological chemistry _cOct 1994 |
||
| 300 |
_a25255-8 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntiviral Agents _xchemistry |
| 650 | 0 | 4 | _aBase Sequence |
| 650 | 0 | 4 |
_aBenzodiazepines _xpharmacology |
| 650 | 0 | 4 |
_aBinding Sites _xgenetics |
| 650 | 0 | 4 |
_aDeoxyguanine Nucleotides _xpharmacology |
| 650 | 0 | 4 | _aDideoxynucleotides |
| 650 | 0 | 4 |
_aDrug Resistance _xgenetics |
| 650 | 0 | 4 |
_aEscherichia coli _xgenetics |
| 650 | 0 | 4 | _aHIV Reverse Transcriptase |
| 650 | 0 | 4 |
_aImidazoles _xpharmacology |
| 650 | 0 | 4 | _aMolecular Sequence Data |
| 650 | 0 | 4 | _aMutagenesis, Site-Directed |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 | _aProtein Conformation |
| 650 | 0 | 4 |
_aRNA-Directed DNA Polymerase _xgenetics |
| 650 | 0 | 4 |
_aRecombinant Proteins _xmetabolism |
| 650 | 0 | 4 | _aReverse Transcriptase Inhibitors |
| 650 | 0 | 4 | _aSequence Analysis, DNA |
| 650 | 0 | 4 | _aSpiro Compounds |
| 650 | 0 | 4 |
_aThymidine _xanalogs & derivatives |
| 650 | 0 | 4 |
_aUridine _xanalogs & derivatives |
| 700 | 1 | _aTaymans, J M | |
| 700 | 1 | _aBalzarini, J | |
| 700 | 1 | _aVelázquez, S | |
| 700 | 1 | _aCamarasa, M J | |
| 700 | 1 | _aDesmyter, J | |
| 700 | 1 | _aDe Clercq, E | |
| 700 | 1 | _aAnné, J | |
| 773 | 0 |
_tThe Journal of biological chemistry _gvol. 269 _gno. 41 _gp. 25255-8 |
|
| 999 |
_c7522850 _d7522850 |
||